BNP Paribas Financial Markets
GMAB icon

BNP Paribas Financial Markets’s Genmab GMAB Stock Holding History

BNP Paribas Financial Markets’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.26M Buy
227,990
+403
+0.2% +$10.7K ﹤0.01% 1940
2026
Q1 		$6.11M Buy
227,587
+179,949
+378% +$5.39M ﹤0.01% 1876
2025
Q4 		$1.47M Buy
47,638
+17,365
+57% +$541K ﹤0.01% 2853
2025
Q3 		$928K Sell
30,273
-17,866
-37% -$435K ﹤0.01% 3185
2025
Q2 		$995K Sell
48,139
-164,185
-77% -$3.37M ﹤0.01% 2913
2025
Q1 		$4.16M Buy
212,324
+89,951
+74% +$1.89M ﹤0.01% 1930
2024
Q4 		$2.55M Buy
+122,373
New +$2.69M ﹤0.01% 2231

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

BNP Paribas Financial Markets's GMAB Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Genmab (GMAB) stake by 0.18% in Q2 2026, buying an estimated $10.7K and bringing the position to 227,990 shares worth $6.26M. The position accounts for ﹤0.01% of the portfolio, ranked #1940.

BNP Paribas Financial Markets first reported a position in GMAB in Q4 2024 and has held it in 7 quarters since. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • BNP Paribas Financial Markets held 227,990 shares of Genmab worth $6.26M as of Q2 2026.
  • BNP Paribas Financial Markets bought 403 Genmab shares in Q2 2026, an estimated $10.7K.
  • Genmab made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #1940 holding.
  • BNP Paribas Financial Markets first reported a position in Genmab in Q4 2024 and has held it in 7 quarters since.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.